The aim of our study was to improve the dissolution of Tramadol hydrochloride (TH) via its semisolid filled lipid based capsules. Sustained release formulation is designed to achieve a prolonged therapeutic effect by continuously releasing medication over an extended period of time after administration of single dose. Semisolid matrixes of TH were prepared by melt-matrix method and were filled in hard gelatin capsule shell (size 0). In this experiment, a mixture of Glycerol monostearate (GMS) and lipid materials like different lipophilic oils and surfactants were used to improve the matrix integrity and drug release. The effects of different oils like Arachis oil, Soyabean oil, castor oil, neobee oil and olive oil and different surfactants such as Span 80, Tween 80, PEG 400, Chremophore RH 40, Cremophor EL were analyzed by formulating at various ratios. The matrices were subjected to the paddle dissolution method using 900 ml of phosphate buffer (pH 6.8). The dissolution test was performed at 100 RPM and the temperature was set at 37 ± 0.5 0 C. The amount of drug was measured from the absorbance with a UV spectrophotometer at 270 nm. The release of drug was plotted in zero order-, 1 st order-and Higuchi-release patterns.
INTRODUCTION
Tramadol, a synthetic opioid of the aminocyclohexanol group, is a centrally acting analgesic with weak opioid agonist properties shown in figure 1 . Tramadol has been proved to be effective in both experimental and clinical pain without causing serious cardiovascular or respiratory side effects. The half-life of the drug is about 5.5 hours and the usual oral dosage regime is 50 to 100 mg every 4 to 6 hours with a maximum dosage of 400 mg/day. To reduce the frequency of administration and to improve patient compliance, a sustainedrelease formulation of tramadol is desirable. The drug is freely soluble in water and hence judicious selection of release retarding excipient is necessary to achieve a constant in vitro release. Filling hard gelatin capsules with semisolid matrices (SSM) is a simple technique that has been used to extend the release of many drugs and obviates the need for additional excipients. 2 It also offers many advantages including improvement in chemical stability, excellent homogeneity and content uniformity, easier formulation of oily drug, and preparation of oral sustained release formulations.
The cost of lipid matrices is also relatively little to produce, and in some cases, it is possible to minimize the influence of physiological variables on drug release. 4 Interest in liquid and semisolid matrix (SSM) filling of hard gelatin capsules was renewed in the late 1970s. 5 Recent decades have seen substantial advances in the use of new excipient mixtures for the filling of hard gelatin capsules and in the technology of their manufacture.
The drug release for extended duration, particularly for highly water-soluble drug, using a hydrophilic matrix system is restricted due to rapid diffusion of the dissolved drug through the hydrophilic gel network. For such drugs with high water solubility, hydrophobic polymers (waxes) are suitable as matrixing agents for developing sustainedrelease dosage forms. Hydrophobic polymers provide several advantages, ranging from good stability at varying pH values and moisture levels to wellestablished safe applications.
SSM capsule formulations offer many advantages over conventional powder filled systems. These include excellent fill weight and content uniformity, the elimination of dust or cross contamination, easier formulation of oily drugs, improved drug stability and easy modification of drug release rate. [6] [7] [8] Tramadol hydrochloride was the model drug in this study which was incorporated in lipid-based semisolid matrix systems to extend its release. In this experiment, different lipophilic oils like Arachis oil, Soyabean oil, castor oil, neobee oil and olive oil and different surfactants such as Span 80, Tween 80, PEG 400, Chremophore RH 40, Cremophor EL were used as the matrix former. 9 In the present study, various matrix systems were designed and tested for controlled delivery of tramadol. The objectives of the study were to investigate the performance of hydrophobic matrix system in controlling the release of this freely soluble drug, and to investigate the effect of lipid matrix as a release-retarding agent, either in the solid melt matrix, so called a hot melt technology when the lipid matrix is being melted with incorporating the drug and defined the release rate of tramadol. 10, 11 
MATERIALS AND METHODS

Tramadol
METHODS
Preparation of semisolid melt-matrix of tramadol HCl. The semisolid lipid matrix was prepared by melt matrix method. According to tables 1-3, the model drug and lipidic excipients accurately weighted and were placed in a 15-ml glass vial and heated on a hot magnetic stirrer to melt the ingredients at the temperature of 70-80ºC. In each case, the mixture was withdrawn by a glass syringe at the volume of 0.5ml for each time and the semisolid matrix was filled in the size 0 hard gelatin capsule shell. In this case, the mixture was withdrawn by a dropper and then filled into the hard gelatin capsule shell by placing the capsule shell die plate on an electronic balance shown in Figure 2 . After solidification of the melt matrix, the capsule shells were stored in an air tight container.
In vitro dissolution study of solid melt matrix.
In vitro dissolution studies from the formulations were carried out for 8, 12 and 24 hours in phosphate buffer (pH 6.8). The solid melt matrices were subjected to the paddle dissolution method using 900 ml of phosphate buffer. The dissolution test was performed at 100 RPM and the temperature was set at 37 ± 0.5ºC. At different interval, samples of 5 ml were withdrawn, filtered and assayed by online spectrophotometer (UVmini-1240, Shimadzu Corporation, Japan) at 270 nm. After each sampling, equal volume (5 ml) of fresh phosphate buffer with the same temperature was replaced.
Analysis by Fourier Transform Infrared (FTIR) spectroscopy. The pure drug and different formulations were subjected to IR spectroscopy using FT-IR spectrophotometer 8400S (SHIMADZU, Kyoto, Japan) shown in figure 8. Their spectra were obtained over the wave number range of 4000 -400 cm -1 . Soyabean Oil (g) 1.5
Table1. Formulations for GMS based melt matrix with different lipophilic oils.
Ingredients
Arachis Oil (g) 1.5
Castor Oil (g) 1.5
Olive Oil (g) 1.5
Neobees oil (g) 1.5 Ingredients (g)  F1  F2  F3  F4  F5  F6  F7  F8  F9  F10  F11  F12 F13  F14 
RESULT AND DISCUSSION
Tramadol Hydrochloride is a potent centrally acting analgesic and is used for the management of moderate to moderately severe pain in adults. It is highly water-soluble drug and the present study was aimed to observe release pattern of drug from the melt matrix by using different lipidic excipients, such as Glyceryl monosterate (GMS), Polyethylene glycol 6000 (PEG 6000), Polyethylene glycol 400 (PEG 400), Soyabean oil. The efficacy of these lipidic excipients on drug release was also evaluated with Span 80, Tween 80, Cremophor EL, Cremophor RH 40 in terms of in vitro drug dissolution. The variables affecting drug dissolution was matrix property, lipid excipients loading and physicochemical property of the drug molecule. Secondary curve was obtained from the release rate of the different formulations.
Effect of different oils on the release of Tramadol HCl from GMS based melt matrix. Figure 3 shows the release of Tramadol HCl from GMS-Oil melt matrix. 1.5gm of Soyabean oil (F1), Arachis oil (F2), Castor oil (F3), Olive oil (F4), and Neobee oil (F5) was added with same amount of GMS and Tramadol HCl to observe the effect of various oils on the release of Tramadol HCl. It was observed that at 8 hours of in vitro dissolution study, F1 (Soyabean oil) gave 29% release, F2 (Arachis oil) gave 33% release, F3 (Castor oil) gave 32% release, F4 (Olive oil) gave 28% release and F5 (Neobee oil) gave 32% release of drug. The release rate was very slow because these oils are hydrophobic in nature and used as the release retarding agent according to figure 4. This test was performed to choose the oil for It was found that Cremophor EL has a marked effect on the release of Tramadol HCl. Formulation F4 (Cremophor EL-0%) showed 35% release of drug after 12 hours. After the addition of Cremophor EL the release of drug was drastically increased. Formulation F5 (Cremophor EL-5%) showed 98% release of drug after 12 hours and formulation F6 (Cremophor EL-10%) showed 100% release of drug after 12 hours. This high release rate of drug from these matrices may be due to the high solubility of Cremophor EL in the matrices.
From figure 7 , it was found that Cremophor RH 40 has a marked effect on the release of Tramadol HCl. Formulation F7( Cremophor RH 40-0%) shows 37% release of drug after 12 hours. After the addition of Cremophor RH 40 the release of drug was drastically increased 82% and 98% from F8 and F9 respectively after 12 hours. This high release rate of drug from these matrices may be due to the high solubility of Cremophor RH 40 in the matrices. 13 Figure 7 shows the release of Tramadol HCl from GMS-Soyabean oil-Span 80 melt matrix. Formulation F10, F11 and F12 showed 46%, 76% and 80% release of the drug after 12 hours of in vitro dissolution test respectively. The release rate from Span 80 was low which may be due to the low HLB value of Span 80. 14 Figure 7 demonstrates the release of Tramadol Hydrochloride from GMS-Soyabean oil-PEG 400 melt matrix. In vitro dissolution study was performed for 12 hours and it was found that the release was increased with the increased concentration of PEG 400. Formulation F13, F14 and F15 showed 27%, 92% and 95% release of drug after 12 hours, respectively. It was found that PEG 400 has a significant effect on the release of drug and the release rate can be controlled by adjusting the amount of PEG 400. The high release rate of drug from these matrices may be due to the high solubility profile of PEG 400. From the graph it is found that all the formulation F1-F14 follows Higuchi release kinetics. Figure 9 shows the DSC thermographs of pure drug Tramadol HCL. Thermographs obtained by DSC studies, revealed that the melting point of pure drug is 185 o C. It may be concluded that, the drug is in the same pure state even in the formulation without interacting with the polymers.
Drug
Analysis by differential scanning calorimetry (DSC).
CONCLUSION
The level of drug loading had very little effect on dissolution results. The choice of lipid excipients was found to have a much more significant impact. The dissolution profiles observed were consistent with the known behavior of the excipients used. In an attempt to prolong drug release using combination of waxes, it was observed that significant improvement in the release retardant activity was found in the melt matrix containing a higher percentage of waxes. As hydrophilic matrix could not control the Tramadol release effectively for more than 12 hours, it is evident from the results that the hydrophobic matrix prepared by the GMS based lipid excipients provide a better system for controlled delivery of a highly water soluble drug, like Tramadol Hydrochloride. On the other hand, using solubilizing agent at a very small ratio provided an increasing release effectively from the melt matrix. Further study in this field is still required to establish this controlled release drug delivery system so that in future it can be used effectively in commercial basis.
